These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 6584541)

  • 1. [Immunologic assessment of urogenital carcinoma].
    Chou YH; Huang CH; Chiang CP
    Taiwan Yi Xue Hui Za Zhi; 1983 Nov; 82(11):1163-9. PubMed ID: 6584541
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the immunologic competence in patients with urogenital cancers. I. Evaluation of nonspecific cellular immunity by delayed cutaneous hypersensitivity test and lymphocytes blastoid formation (author's transl)].
    Ono H
    Nihon Hinyokika Gakkai Zasshi; 1981 Aug; 72(8):1064-77. PubMed ID: 7198700
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparative evaluation on nonspecific immunoparameters and CEA as a tumor marker in urogenital cancer patients.
    Nakagami Y; Minowa T; Tozuka K; Hiraoka Y; Chin H; Matsumoto K
    Nihon Ika Daigaku Zasshi; 1983 Apr; 50(2):292-4. PubMed ID: 6683278
    [No Abstract]   [Full Text] [Related]  

  • 4. Correlations among cutaneous reactivity to DNCB, PHA-induced lymphocyte blastogenesis and peripheral blood E rosettes.
    Catalona WJ; Tarpley JL; Potvin C; Chretien PB
    Clin Exp Immunol; 1975 Feb; 19(2):327-33. PubMed ID: 1082390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host immunocompetence in genitourinary cancer: relation to tumor stage and prognosis.
    Catalona WJ; Tarpley JL; Potvin C; Chretien PB
    Natl Cancer Inst Monogr; 1978 Dec; (49):105-10. PubMed ID: 311891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis on lymphocyte electrophoretic mobility pattern in urogenital cancer patients].
    Nakagami Y; Minowa T; Tozuka K; Hiraoka Y; Nakajima H; Matsumoto K
    Nihon Hinyokika Gakkai Zasshi; 1983 Oct; 74(10):1727-33. PubMed ID: 6676552
    [No Abstract]   [Full Text] [Related]  

  • 7. Preliminary report of an immunological study in urological cancer.
    Serrallach N; Jimenez JF; Aguiló F; Anguera A; Clavo M; Orejas V; Torner V; Serrate R
    Eur Urol; 1975; 1(2):99-100. PubMed ID: 1241896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of lymphocyte electrophoresis in patients with urogenital cancers.
    Nakagami Y; Minowa T; Tozuka K; Hiraoka Y; Matsumoto K
    Nihon Ika Daigaku Zasshi; 1983 Oct; 50(5):766-8. PubMed ID: 6662903
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibody induction of lymphocyte-mediated cytotoxicity against human transitional-cell carcinomas of the urinary tract.
    Hakala TR; Lange PH; Castro AE; Elliott AY; Fraley EE
    N Engl J Med; 1974 Sep; 291(13):637-41. PubMed ID: 4859212
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cellular immunology of malignancies of urogenital tract (author's transl)].
    Ikegami K
    Nihon Hinyokika Gakkai Zasshi; 1977 Sep; 68(9):832-5. PubMed ID: 303720
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunologic assays in lung cancer. Skin tests, lymphocyte blastogenesis, and rosette-forming cell count.
    Brugarolas A; Han T; Takita H; Minowada J
    N Y State J Med; 1973 Mar; 73(6):747-50. PubMed ID: 4510958
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphocyte-induced angiogenesis assay--in cutaneous malignancies and cutaneous and genital warts.
    Szmurło A; Grzesik W
    Arch Immunol Ther Exp (Warsz); 1988; 36(1):85-7. PubMed ID: 2466452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phytohaemagglutinin (PHA) induced cytotoxicity III: Cell mediated immunoresponsiveness in genitourinary cancer patients (author's transl)].
    Aoki S
    Nihon Hinyokika Gakkai Zasshi; 1978 Nov; 69(11):1412-21. PubMed ID: 739706
    [No Abstract]   [Full Text] [Related]  

  • 14. Cutaneous response to dinitrochlorobenzene in patients with genito-urinary cancers.
    Duclos H; Schwarzenberg L; Duclos SH; Hugues H; Kuss R
    Biomedicine; 1977 Jan; 27(1):43-7. PubMed ID: 856314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transitional cell and renal carcinoma: cell-mediated immunity as determined by the lymphocyte titration technique.
    Hakala TR
    Natl Cancer Inst Monogr; 1978 Dec; (49):151-2. PubMed ID: 571043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical evaluation of lymphocyte functions in urological cancer patients.
    Elhilali MM; Paika KD; Brosman S; Fahey JL
    Cancer Res; 1976 Jan; 36(1):132-7. PubMed ID: 1082369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large granular lymphocytes in blood of healthy donors and patients with tumors.
    Korcáková L; Pazourek J; Jarosíková T; Holub M
    Neoplasma; 1983; 30(2):181-5. PubMed ID: 6843723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the immunologic competence in patients with urogenital cancers. II. The effect of abnormal serum proteins on nonspecific cellular immunity (author's transl)].
    Ono H
    Nihon Hinyokika Gakkai Zasshi; 1981 Aug; 72(8):1078-91. PubMed ID: 7198701
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunologic defects in melanoma patients: lack of effect of BCG therapy.
    Gersten MJ; Hadden EM; Kaplan MH; Pinsky CM; Armstrong D; Hadden JW
    Clin Bull; 1977; 7(2):63-9. PubMed ID: 902403
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies of immunotherapy of malignant urogenital tumors: 2nd report. Changes in the K-cell population of the peripheral blood in patients with malignant tumors and the significance of antibody dependent cell-mediated cytotoxicity (ADCC) in OK-432 immunotherapy].
    Fujioka T; Tanji S; Koike H; Suzuki K; Aoki H; Banya Y; Kubo T; Ohhori T
    Nihon Hinyokika Gakkai Zasshi; 1987 Jan; 78(1):29-38. PubMed ID: 3599595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.